Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate in Immune Related Arthritis or Arthralgias
NCT06001125Phase 2Terminated
- Sponsor
- American Health Staffing Group
- Start
- Aug 2024
- Primary completion
- Jun 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of methotrexate in arthritis and arthralgia, sponsored by American Health Staffing Group. Primary endpoint: Discontinuation of Prednisone at 12 weeks. Started Aug 2024; status: terminated.
02
Drugs
methotrexate
03
Conditions
arthritisarthralgia
Beyond the preview
Go deeper on NCT06001125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06001125.